Pharming Group (PHAR) Q2 2025 Earnings Report

241 Followers

PHAR Q2 2025 EPS Results

Actual EPS$0.06

Consensus EPS-$0.10

Beat/MissBeat by +$0.16

One Year Ago EPS-$0.02

Actual Revenue$94.45M

Expected Revenue$82.63M

Beat/MissBeat by +$11.82M

YoY Revenue Growth+27.58%

QuarterQ2 2025

Date07/31/2025

TimeBefore Open

Conference CallThursday, July 31, 2025

PHAR Upcoming Earnings

Pharming Group's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

PHAR Q2 2025 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q3)	0.16 / -	0.1	―
Jul 30, 2026	2026 (Q2)	0.06 / 0.02	0.06	-66.67% (-0.04)
May 07, 2026	2026 (Q1)	<0.01 / -0.07	-0.22	68.18% (+0.15)
Mar 12, 2026	2025 (Q4)	0.01 / 0.07	0.05	40.00% (+0.02)
Nov 06, 2025	2025 (Q3)	<0.01 / 0.10	-0.02	600.00% (+0.12)
Jul 31, 2025	2025 (Q2)	-0.10 / 0.06	-0.02	400.00% (+0.08)
May 08, 2025	2025 (Q1)	-0.03 / -0.22	-0.19	-15.79% (-0.03)
Mar 13, 2025	2024 (Q4)	0.02 / 0.05	-0.04	225.00% (+0.09)
Oct 24, 2024	2024 (Q3)	>-0.01 / -0.02	0.005	-500.00% (-0.03)
Aug 01, 2024	2024 (Q2)	>-0.01 / -0.02	0.01	-300.00% (-0.03)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed